Galaxy FCT - Solid H2 Logistics
3.3.  Vaccine Cold Chain Back Up Energy Supply ("VES")
25% of Vaccines are degraded 
due to temperature excursion




Sudden explosion of COVID 19 vaccines will only magnify the problem







Huge addressable market for VES in Vaccine Cold Chain and for storage in remote/rural locations

A report by IATA in 2019 estimates that around 25% of vaccines are degraded (due to temperature excursions) between the point of production and the arm of the intended recipient.  Annual losses are estimated in 2019 to be in the region of USD 34 billion - and these are pre-COVID 19 numbers.

With additional 12 to 15 billion doses of COVID 19 vaccines estimated to be required  globally in addition to these and the need for even lower temperatures required by MRNA type vaccines (Pfizer at -70C and Moderna at -20C), we anticipate the problem with Vaccine logistics to bet even more complex.  This will be exacerbated by the rise of more and more variants/mutations which makes it even more urgent to ensure that vaccines are efficiently moved right across the planet - to ensure that people in remote locations are also vaccinated.  They often say that "No one is safe until everyone is".  

There are lots of measures taken to improve vaccine storage and logistics, all of which require significant energy resources.  Solid H2 Logistics, through VES will have a huge addressable market particularly in the logistic cold chain process and also in areas where the electricity supply can be unreliable.